Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): A study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity
Malaria remains a major public health burden despite approval for implementation of a partially effective pre-erythrocytic malaria vaccine. There is an urgent need to accelerate development of a more effective multi-stage vaccine. Adults in malaria endemic areas may have substantial immunity provide...
Main Authors: | Kapulu, MC, Njuguna, P, Hamaluba, MM, Chmi-Sika Study Team |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000Research
2019
|
Similar Items
-
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity [version 2; peer review: 2 approved]
by: Melissa C. Kapulu, et al.
Published: (2019-11-01) -
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
by: Kapulu, MC, et al.
Published: (2022) -
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
by: Fauzia K. Musasia, et al.
Published: (2022-07-01) -
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
by: Melissa C. Kapulu, et al.
Published: (2021-09-01) -
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
by: Musasia, FK, et al.
Published: (2022)